1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Metastases

Capivasertib with abiraterone for treating hormone-sensitive metastatic prostate cancer with PTEN deficiency ID 6466

Awaiting development [GID-TA11583] Expected publication date: TBC

  • Project information
  • Project documents

30225-Capivasertib-Abiraterone-Acetate-for-Prostate-Cancer-V1.0-MAY2024-NON-CONF.pdf (nihr.ac.uk)